IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 13 filers reported holding IMMIX BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,378 | +27.1% | 15,900 | 0.0% | 0.00% | +100.0% |
Q2 2023 | $42,771 | +47.8% | 15,900 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $28,938 | -20.5% | 15,900 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $36,411 | +65.5% | 15,900 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $22,000 | -46.3% | 15,900 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $41,000 | +7.9% | 15,900 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $38,000 | – | 15,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynwood Capital Management Inc. | 200,250 | $538,673 | 0.68% |
Imprint Wealth LLC | 22,280 | $42,332 | 0.03% |
Moss Adams Wealth Advisors LLC | 20,000 | $53,800 | 0.02% |
Koshinski Asset Management, Inc. | 51,001 | $137,193 | 0.02% |
UMB Bank, n.a. | 72,639 | $195,399 | 0.00% |
InterOcean Capital Group, LLC | 15,900 | $42,771 | 0.00% |
WELLS FARGO & COMPANY/MN | 42 | $113 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 60,326 | $162,276 | 0.00% |
STATE STREET CORP | 42,960 | $115,562 | 0.00% |